U.S. Markets closed

From generic drugs to gummies: Boulder CBD company buys Novartis pharmaceutical plant in Broomfield for $18.8M

Andrew Dodson
From generic drugs to gummies: Boulder CBD company buys Novartis pharmaceutical plant in Broomfield for $18.8M

A large pharmaceutical plant in Broomfield that for years produced generic drugs has been bought by a Boulder CBD company that’s looking to expand its ingredient-selling business to manufacturing mainstream products, like gummies, tablets and topicals. Mile High Labs purchased Novartis AG’s (NYSE: NVS) Sandoz plant in Broomfield, 2555 W. Midway Blvd., on Wednesday, June 19, for $18.8 million, company officials confirmed to Denver Business Journal.